500024-27-1

Basic information

• Product Name: Methyl 2-cyano-3-Methylbenzoate
• Synonyms: Methyl 2-cyano-3-Methylbenzoate;2-Cyano-3-methyl-benzoic acid methyl ester
• CAS NO: 500024-27-1
• Molecular Formula: C₁₀H₉NO₂
• Molecular Weight: 175.18396
• EINECS: -0
• Mol File: 500024-27-1.mol

Chemical Properties

• Boiling Point: 316.4±30.0 °C(Predicted)
• Appearance: /
• Density: 1.15±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl 2-cyano-3-Methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-cyano-3-Methylbenzoate(500024-27-1)
• EPA Substance Registry System: Methyl 2-cyano-3-Methylbenzoate(500024-27-1)

Safety Data

• Hazardous Substances Data: 500024-27-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-cyano-3-methylbenzoate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of various medicinal compounds.
Used in Agrochemical Industry:
Methyl 2-cyano-3-Methylbenzoate serves as an intermediate in the synthesis of agrochemicals, playing a role in the production of substances that help protect crops and enhance agricultural productivity.
Used in Dye and Pigment Production:
Methyl 2-cyano-3-methylbenzoate is used in the production of organic dyes and pigments, contributing to the coloration and quality of various products in different industries.
It is important to handle Methyl 2-cyano-3-methylbenzoate with care, as it may irritate the skin and eyes upon contact.

InChI:InChI=1S/C10H9NO2/c1-7-4-3-5-8(9(7)6-11)10(12)13-2/h3-5H,1-2H3

Upstream product

• 22223-49-0 methyl 2-amino-3-methylbenzoate 
• 5437-38-7 3-methyl-2-nitrobenzoic acid 
• 5471-82-9 methyl 3-methyl-2-nitrobenzoate 
• 99-04-7 m-Toluic acid 
• 53663-39-1 3-methyl-2-bromobenzoic acid 
• 131001-86-0 methyl 2-bromo-3-methylbenzoate 
• 557-21-1 zinc(II) cyanide 

Downstream Products

• 37102-74-2 3-methylphthalic acid 

Relevant articles and documents

QUINAZOLINEDIONES AS TANKYRASE INHIBITORS

This invention relates to the use of quinazolinediones for the modulation, notably the inhibition of the activity of tankyrases (TNKS1 and TNKS2). Suitably, the present invention relates to the use of quinazolinediones in the treatment of cancer, fibrosis and other hyperproliferative diseases through this mechanism.

Design, synthesis and identification of novel colchicine-derived immunosuppressant

Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A.